Dr. DERM Psoriasis Cream, developed by professional dermatologists, treats the symptoms of psoriasis while moisturizing and rebuilding the skin's protective barrier. An antipsoriasis drug removes scales and dead cells and helps restore moisture to the skin, preventing psoriasis symptoms from recurring. Using the medicine helps to stop aggravated symptoms quickly and cure psoriasis in a short course.
Pre-cleanse the skin with a neutral lotion. Apply Dr. DERM to affected areas one to four times a day or as directed by a doctor. You can also view the patient information included with the product.
Instructions for applying the preparation:
Inflamed skin is sensitive to UV rays. Avoid direct sunlight on wounds during therapy. Use sunscreen, wear protective clothing and limit sun exposure while using Dr. DERM and within one week of completing the treatment procedures. The recommended course of therapy is 28 days. Doctors recommend repeating the treatment after 2-3 months for prevention purposes.
Term | Effect |
---|---|
Week 1 | The cream removes inflammation, itching, flaking, plaques. |
Week 2 | The regeneration process of damaged tissue is initiated due to the normalization of the cell division cycle. |
Week 3 | The pH of the body is normalized, the skin tone is increased. The skin becomes firm and elastic. |
Week 4 | If you are on a diet, the disease will not get worse. |
Dr. DERM is indicated for the treatment of mild to moderate psoriasis. The drug reduces inflammation, reduces itching, and slows down cell production. Types of psoriasis for which the use of the cream is recommended:
Dr. DERM should be applied directly to the affected area during treatment or when symptoms are increasing.
The drug against psoriasis Dr. DERM is based on natural hypoallergenic components and does not cause side reactions. The use of the medicine is not recommended in the following cases:
Care should be taken when using the cream in case of a pronounced allergic reaction to the components of the drug. The drug has passed all stages of clinical trials under laboratory conditions in Portugal.